A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
about
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressantsNeuroplasticity and the next wave of antidepressant strategiesPreclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extractMourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatryKetamine and other glutamate receptor modulators for depression in bipolar disorder in adultsKetamine and other glutamate receptor modulators for depression in bipolar disorder in adultsKetamine and other glutamate receptor modulators for depression in adultsAntidepressants for people with epilepsy and depressionAntidepressants for people with epilepsy and depressionSigma receptors: potential targets for a new class of antidepressant drugA Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderRapid antidepressant effects: moving right alongmTOR activation is required for the antidepressant effects of mGluR₂/₃ blockadeReplication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialGlycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male ratsA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionTowards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersGlutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatmentHCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine.The molecular neurobiology of depressionKetamine enantiomers in the rapid and sustained antidepressant effectsPractical application of the neuroregenerative properties of ketamine: real world treatment experiencePreclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistComorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic IllnessDepression as a Glial-Based Synaptic DysfunctionTreatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as TherapyInflammation and immunity in schizophrenia: implications for pathophysiology and treatmentPotential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsZinc in the Glutamatergic Theory of DepressionPharmacological approaches to the challenge of treatment-resistant depressionGlia in the cytokine-mediated onset of depression: fine tuning the immune responseLegal highs: staying on top of the flood of novel psychoactive substancesAntidepressant mechanism of ketamine: perspective from preclinical studiesContribution of NMDA receptors to dorsolateral prefrontal cortical networks in primatesAntidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a reviewNeurological diseases and painThe neurology of mTORKetamine, sleep, and depression: current status and new questions
P2860
Q21129276-EC896B4F-29B2-48BC-9D07-C8F652B1CA8CQ21129480-BD8761FB-FECC-4CBA-901D-52249F1278B8Q21132322-78328E68-24C1-42B1-9BEC-334B3DA16715Q21203922-E5957173-2710-4C69-8DAA-5A2DDC459C7CQ22252957-9223D13F-1A6E-4373-BD42-AE0935EAA881Q24186726-1F15A6B2-1FD9-4B8B-9ECB-FBDA70C32CBCQ24186746-0A476066-76BB-4209-85AF-6E4CAE8B7282Q24187468-D44D7BCB-1C0A-451F-9FB0-AB6A81D342B4Q24201510-4D95E695-C32A-44FC-B72C-96E7F28A9135Q24567770-5CA2DA71-4CEC-4134-80EF-FDFD541788DEQ24602988-ED59C651-0E89-4C52-9064-4D044CED7B82Q24614410-9CBDAFF5-C69C-4C62-897D-5ABC3DF52274Q24617166-081079C4-2E9A-41AC-B52E-4E97058F0E07Q24629398-6521016C-EC2E-4EA8-AC2C-B546F4ACDA1CQ24629780-C569A516-FCF0-4292-9024-E5F0469E432EQ24630153-03B8AB5B-8FA5-48B1-AA20-2A2C7326C0C2Q24632936-5BDBF652-B18F-4E04-892A-A19AA58EF851Q24633004-E0D30860-03CF-4C3F-B874-059416C86505Q24653694-56D170DE-59EA-4A75-951D-237900327923Q24656261-B4AC7173-4DF6-46FA-A12B-28FE8285165AQ26746141-23D84495-A87E-4985-8003-48F26AB9F1C2Q26748766-ED511AEB-D8AC-432A-92FD-F17ECBB8D811Q26750021-F6218FCF-7300-4884-B804-DEBD1EF89F46Q26765501-B8B29061-9FFA-4170-8D9C-6276BB5C1136Q26772830-CE6CB36D-3E5C-4E69-8F25-92900A17B6ADQ26773084-F29F4837-FD87-4393-8477-2EFB94B5827BQ26781620-93B0A8E8-AEEF-4561-B7E2-5C5B69C1C986Q26782274-33E7BEF4-D86A-40DF-B25A-4768EB4AFDDAQ26782993-5C4BD0D3-137D-40D1-AEFD-06540650F953Q26782997-44E7F48A-1679-4262-B35F-3973101FAB3AQ26786214-FA90AE40-EC34-4EBF-BF95-18396247F2CAQ26798241-242E42E3-A673-4D1C-A8BC-850ADF43A6ADQ26798929-F4B8BD26-711B-4CAE-9E1B-F0C49C2D8DAEQ26799231-8FB72161-469D-4F57-9A62-A27BEF73F9DFQ26800231-4309E453-1231-4D3E-95D5-6FA2ADC5F643Q26820417-48192024-5DF9-4E5E-9EC4-A6BE3C31B94DQ26822244-530793EA-D9D5-4E3D-AB17-C7CEA83EB7D5Q26822891-7A00EABE-B7E0-4177-A49A-0F0756BFC702Q26824286-E7728646-0914-407E-BBB0-A87C1B15B887Q26828564-3183D03B-A4DA-4D01-9233-74FE3366254B
P2860
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A randomized trial of an N-met ...... ent-resistant major depression
@ast
A randomized trial of an N-met ...... ent-resistant major depression
@en
type
label
A randomized trial of an N-met ...... ent-resistant major depression
@ast
A randomized trial of an N-met ...... ent-resistant major depression
@en
prefLabel
A randomized trial of an N-met ...... ent-resistant major depression
@ast
A randomized trial of an N-met ...... ent-resistant major depression
@en
P2093
P3181
P1433
P1476
A randomized trial of an N-met ...... ent-resistant major depression
@en
P2093
Brutsche NE
Carlson PJ
Charney DS
Luckenbaugh DA
Zarate CA Jr
P304
P3181
P356
10.1001/ARCHPSYC.63.8.856
P407
P577
2006-08-01T00:00:00Z